AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Precigen, Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001SSB3T5
6.19▼ 0.20 (-3.13%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
6.39
Day's Range
6.15 – 6.38
52-Week Range
3.04 – 8.98
Volume
4.2M
Avg Volume
5.3M
Share Statistics
Shares Outstanding
Employees
47
Exchange
XNAS
Listed
2013-08-08
Share count as of July 31, 2026

Precigen, Inc. Common Stock (PGEN) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Precigen, Inc. Common Stock (PGEN)
What is Precigen, Inc. Common Stock's Market Cap?
Precigen, Inc. Common Stock's Market Cap is $2.2B, based on as-reported figures from SEC (XBRL) filings.
What is Precigen, Inc. Common Stock's Enterprise Value?
Precigen, Inc. Common Stock's Enterprise Value is $2.3B, based on as-reported figures from SEC (XBRL) filings.
What is Precigen, Inc. Common Stock's Price / Sales?
Precigen, Inc. Common Stock's Price / Sales is 25.9×, based on as-reported figures from SEC (XBRL) filings.
What is Precigen, Inc. Common Stock's EV / Revenue?
Precigen, Inc. Common Stock's EV / Revenue is 26.5×, based on as-reported figures from SEC (XBRL) filings.
What is Precigen, Inc. Common Stock's EV / EBITDA?
Precigen, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Precigen, Inc. Common Stock's Revenue (TTM)?
Precigen, Inc. Common Stock's Revenue (TTM) is $85.7M, based on as-reported figures from SEC (XBRL) filings.
What is Precigen, Inc. Common Stock's Net Income (TTM)?
Precigen, Inc. Common Stock's Net Income (TTM) is -$157.7M, based on as-reported figures from SEC (XBRL) filings.
What is Precigen, Inc. Common Stock's EBITDA?
Precigen, Inc. Common Stock's EBITDA is -$35.4M, based on as-reported figures from SEC (XBRL) filings.
What is Precigen, Inc. Common Stock's Diluted EPS (TTM)?
Precigen, Inc. Common Stock's Diluted EPS (TTM) is -0.44, based on as-reported figures from SEC (XBRL) filings.
What is Precigen, Inc. Common Stock's EBITDA Margin?
Precigen, Inc. Common Stock's EBITDA Margin is -41.3%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · PGENAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenues
Total revenues
YoY growth+6322.7%+1633.9%+283.6%+206.6%
Operating Expenses
Cost of products and services——
Research and development
Selling, general and administrative
Impairment of goodwill—
Total operating expenses
% of revenue58.8%125.8%574.6%1280.0%
Operating income (loss)
% of revenue41.2%-25.8%-474.6%-1180.0%
Other Income (Expense), Net
Change in fair value of warrant liabilities
Interest expense
Interest income
Other income (expense), net
Total other income (expense), net
Income (loss) before income taxes
Income tax expense
Net Income (loss)
% of revenue36.5%-34.1%-514.9%-5008.4%
Net income (loss) per share, basic (in dollars per share)
Net income (loss) per share, diluted (in dollars per share)